Topiramate in migraine prevention: Results of a large controlled trial

Archives of Neurology

Volumn 61, Issue 4, 2004, Pages 490-495

  Silberstein, Stephen D ^a,c,d   Neto, Walter ^b   Schmitt, Jennifer ^b   Jacobs, David ^b  

^a JEFFERSON HEADACHE CENTER   (United States)

^b JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^c GLAXOSMITHKLINE   (United States)

^d THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PLACEBO; TOPIRAMATE; DRUG DERIVATIVE; FRUCTOSE;

ADOLESCENT; ADULT; AGED; ANOREXIA; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MIGRAINE; NAUSEA; NEPHROLITHIASIS; PARESTHESIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SOMNOLENCE; TASTE DISORDER; WEIGHT REDUCTION; DOSE RESPONSE; MIDDLE AGED; MULTICENTER STUDY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FRUCTOSE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; TREATMENT OUTCOME;

EID: 2342461018     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.61.4.490     Document Type: Article

References (21)

1. Silberstein SD, Lipton RB, Goadsby PJ. Headache in Clinical Practice. 2nd ed. Oxford, England: Martin Dunitz; 2002.
2. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41:646-657.
3. Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;55:754-762.
4. Connor GS. A double-blind placebo-controlled trial of topiramate treatment for essential tremor. Neurology. 2002;59:132-134.
5. Johnson BA, Ait-Daoud N, Bowden CL, et al. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet. 2003;361:1677-1685.
6. Berlant J, van Kammen DP. Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder; a preliminary report. J Clin Psychiatry. 2002;63:15-20.
7. McElroy SL, Arnold LM, Shapira NA, et al. Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial. Am J Psychiatry. 2003;160:255-261.
8. Hoopes SP, Reimherr FW, Hedges DW, et al. Topiramate in the treatment of bulimia nervosa: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2003;64:1335-1341.
9. Von Seggern RL, Mannix LK, Adelman JU. Efficacy of topiramate in migraine prophylaxis: a retrospective chart analysis. Headache. 2002;42:804-809.
10. Young WB, Hopkins MM, Shechter AL, Silberstein SD. Topiramate: a case series study in migraine prophylaxis. Cephalalgia. 2002;22:659-663.
11. Edwards KR, Potter DL, Wu S-C, Kamin M, Hulihan J. Topiramate in the preventive treatment of episodic migraine: a combined analysis from pilot, double-blind, placebo-controlled trials. CNS Spectr. 2003;8:428-432.
12. Headache Classification Committee of the International Headache Society. Classification and Diagnostic Criteria for Headache Disorders, Cranial Neuralgias and Facial Pain. Oslo, Norway: Norwegian University Press; 1988.
13. International Headache Society Clinical Trials Subcommittee. Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia. 2000;20:765-786.
14. Tukey JW, Ciminera JL, Heyse JF. Testing the statistical certainty of a response to increasing doses of a drug. Biometrics. 1985;41:295-301.
15. Mathew NT, Saper JR, Silberstein SD, et al. Migraine prophylaxis with divalproex. Arch Neurol. 1995;52:281-286.
16. Klapper J. Divalproex sodium in migraine prophylaxis: a dose-controlled study. Cephalalgia. 1997;17:103-108.
17. Freitag FG, Collins SD, Carlson HA, et al. A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis. Neurology. 2002;58:1652-1659.
18. Mathew NT, Magnus-Miller L, Saper J, et al. Migraine prophylaxis with gabapentin [abstract]. Headache. 1999;39:367.
19. International Headache Society Committee on Clinical Trials in Migraine. Guidelines for controlled trials of drugs in migraine: first edition. Cephalalgia. 1991;11:1-12.
20. Couch JR, Hassanein RS. Amitriptyline in migraine prophylaxis. Arch Neurol. 1979;36:695-699.
21. Tfelt-Hansen P, Standnes B, Kangasneimi P, Hakkarainen H, Olesen J. Timolol vs propranolol vs placebo in common migraine prophylaxis: a double-blind multicenter trial. Acta Neurol Scand. 1984;69:1-8.